JCAD and chronic obstructive pulmonary disease: To mimic the pro-inflammatory environment seen in COPD pathology in an in vitro setting, we treated HPMECs with TNF-α (tumor necrosis factor-α) (or vehicle as controls) for 6 h after first silencing them with KIAA1462 siRNA or mock siRNA as controls.